Dr. Sid O’Bryant is leading the charge to use blood biomarkers to bring the first-ever primary care blood test to market for America’s seniors. His work runs counter to the areas of focus of many other researchers, but his discoveries could pave the way for significant advancements in the diagnosis and treatment of Alzheimer’s, Parkinson’s and other neurodegenerative diseases. He just received a $45 million grant to continue to study the ways that Alzheimer’s Disease impacts people of different ethnicities and his work could hold the keys to understanding these complex diseases.

This is part one of a two part series featuring Dr. Sid O’Bryant and his work to address senior citizen’s biggest fear – developing dementia.